Advertisement

Topics

Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space

07:30 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Asuragen, Inc., a global molecular diagnostics company, announced today the availability of the AmplideX® PCR/CE TOMM40 Kit1 for research use only to advance studies of neurodegeneration, dementia progression, and Alzhei...

Other Sources for this Article

Asuragen, Inc.
Lynne Hohlfeld
SVP, Corporate Development and Chief Financial Officer
lhohlfeld@asuragen.com

NEXT ARTICLE

More From BioPortfolio on "Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...